Cue Biopharma GAAP EPS of $0.01, revenue of $21.94M
Source: SeekingAlpha
2026-03-17 10:48:09 ET
More on Cue Biopharma
- Cue Biopharma prices $10M underwritten public offering; shares down
- Cue Biopharma launches proposed public offering of shares and warrants
- Seeking Alpha’s Quant Rating on Cue Biopharma
- Historical earnings data for Cue Biopharma
- Financial information for Cue Biopharma
Read the full article on Seeking Alpha
For further details see:
Cue Biopharma GAAP EPS of $0.01, revenue of $21.94M
Cue Biopharma Inc.
NASDAQ: CUE
CUE Trading
-5.18% G/L:
$0.2492 Last:
438,060 Volume:
$0.2577 Open:
CUE Latest News
March 16, 2026 04:05:00 pm
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
CUE Stock Data
$30,117,989
80,549,371
0.16%
23
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
